NCT05354570 - A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Thymic MalignanciesPleural Metastases

Interventions

RADIATION

Intensity-Modulated Pleural Radiation Therapy (IMPRINT)

Radiation therapy will be administered over approximately 6 weeks at 50.4 Gy in 28 fractions, including an optional dose-painting SIB to gross residual disease up to 60 Gy while respecting normal tissue constraints.

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER